Future approaches for the therapy of malignant glioma: targeting genes mediating invasion

Author： Emdad Luni   Dent Paul   Sarkar Devanand   Fisher Paul B  

Publisher： Future Medicine

ISSN： 1479-6694

Source： Future Oncology, Vol.8, Iss.4, 2012-04, pp. : 343-346

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Targeting integrins in malignant glioma

By Tabatabai Ghazaleh  

Targeted Oncology, Vol. 5, Iss. 3, 2010-09 ,pp. : 175-181

Springer Publishing Company

Access to resources Recommend Favorite

Therapeutic Targeting of Malignant Glioma

By  

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 14, Iss. 8, 2014-10 ,pp. : 1075-1084

Bentham Science Publishers

Access to resources Recommend Favorite

Trends in Malignant Glioma Monoclonal Antibody Therapy

By  

Current Cancer Therapy Reviews, Vol. 11, Iss. 2, 2015-06 ,pp. : 102-118

Bentham Science Publishers

Access to resources Recommend Favorite

miR-203 sensitizes glioma cells to temozolomide and inhibits glioma cell invasion by targeting E2F3

By        

Molecular Medicine Reports, Vol. 11, Iss. 4, 2015-01 ,pp. : 2838-2844

Spandidos Publications

Access to resources Recommend Favorite

Lipid metabolism emerges as a promising target for malignant glioma therapy

By Guo Deliang   Bell Erica Hlavin   Chakravarti Arnab  

CNS Oncology, Vol. 2, Iss. 3, 2013-05 ,pp. : 289-299

Future Medicine

Access to resources Recommend Favorite